Bisnorcymserine

N/A

Report date: 2025/06/13 15:50:21
NME

Base Information

Drug NameBisnorcymserine
Drug Alias NameBNCBisnorcymcerineANVS-301
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIslet amyloid polypeptide inhibitorsButyrylcholinesterase inhibitors
TargetsIslet amyloid polypeptideButyrylcholinesterase
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesHorizon Therapeutics PLCNational Institute On Aging (NIA)
China Registration ClassN/A

Develop Information

Active CompaniesHorizon Therapeutics PLCQr Pharma
Inactive CompaniesNational Institute On Aging (NIA)
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A